Clinical Trials Logo

Nephrogenic Fibrosing Dermopathy clinical trials

View clinical trials related to Nephrogenic Fibrosing Dermopathy.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT00677092 Active, not recruiting - Clinical trials for Nephrogenic Systemic Fibrosis

Pilot Study of Imatinib Mesylate to Treat Nephrogenic Systemic Fibrosis

GENESYF
Start date: May 2008
Phase: Phase 2
Study type: Interventional

- To determine the efficacy of imatinib mesylate in reducing cutaneous thickening and tethering in patients with nephrogenic systemic fibrosis (NSF). - To assess the safety and tolerability of imatinib mesylate in patients with chronic kidney disease and NSF.